Showing results (1-10 of 321) with videos related to
Sort By:
Pageof 33
Journal of Interprofessional Care|December 12, 2018
Challenges in delivering personalised support to people with multiple and complex needs: qualitative studyJoanne Neale, Tom Parkman, John StrangAddiction (Abingdon, England)|June 30, 2015
Naloxone--does over-antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin/opioid overdoseJoanne Neale, John StrangSubstance Use & Misuse|August 21, 2024
Long-Acting Injectable Buprenorphine for Opioid Use Disorder: A Qualitative Analysis of Patients' Interpersonal Relationships during the First Year of TreatmentJoanne Neale, John StrangBMC Health Services Research|February 18, 2017
Qualitative exploration of why people repeatedly attend emergency departments for alcohol-related reasonsTom Parkman, Joanne Neale, Ed Day, et al.Addiction (Abingdon, England)|February 22, 2023
How do patients feel during the first 72 h after initiating long-acting injectable buprenorphine? An embodied qualitative analysisJoanne Neale, Stephen Parkin, John StrangThe International Journal on Drug Policy|October 21, 2023
Conceptualising retention in treatment with long-acting injectable buprenorphine (for opioid use disorder) as a journey: Findings from a longitudinal qualitative studyStephen Parkin, Joanne Neale, John StrangSubstance Use & Misuse|August 12, 2023
Non-Prescribed Substance Use during the First Month of Treatment by People Receiving Depot Buprenorphine for Opioid Use DisorderStephen Parkin, Joanne Neale, John StrangSubstance Abuse Treatment, Prevention, and Policy|June 22, 2023
Patients' goals when initiating long-acting injectable buprenorphine treatment for opioid use disorder: findings from a longitudinal qualitative studyJoanne Neale, Stephen Parkin, John StrangAddiction (Abingdon, England)|August 21, 2016
Development of a proto-typology of opiate overdose onsetJoanne Neale, Julia Bradford, John StrangThe International Journal on Drug Policy|June 6, 2024
'Matters-of-concern' associated with discontinuation of long-acting injectable buprenorphine: Findings from a longitudinal qualitative studyStephen Parkin, Joanne Neale, John StrangPageof 33